Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Negotiating: Careful Choice of Words Increases Chances of Success

  • Insight creates new memories in the brain

  • Using Twitter to probe political polarization

  • Wobbly no more: Work on analogical processing helps children learn key engineering principle

  • How are ordinary consumers transforming the fashion business?

  • When are consumers more likely to rely on feelings to make decisions?

  • Saving money: Do consumers spend less if they think about the future?

  • Cultivating timeflow: Can consumers shape how they experience time?

  • Scientists one step closer to finding how to repair damaged nerve cells

  • Chronic loneliness in older adults leads to more doctors' office visits, study finds

  •